Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01667887
Other study ID # MotionLoc Screw
Secondary ID
Status Completed
Phase N/A
First received August 15, 2012
Last updated January 28, 2013
Start date April 2011
Est. completion date January 2013

Study information

Verified date January 2013
Source Legacy Biomechanics Laboratory
Contact n/a
Is FDA regulated No
Health authority United States: Legacy IRB
Study type Observational

Clinical Trial Summary

The objective of this study is to document callus formation and healing of fractures stabilized with locking plates utilizing modern MotionLoc screws that provide controlled axial micro-motion to actively promote fracture healing.


Description:

Rigid locked plating constructs can suppress fracture healing, particularly at the near cortex adjacent to the plate where interfragmentary motion is minimal. Dynamic fixation with Far Cortical Locking (FCL) screws reduces construct stiffness and induces axial interfragmentary motion to stimulate symmetric callus formation and healing. Two versions of FCL screws are commercially available, but the clinical durability of this novel concept has not been documented to date. This prospective observational study documented our early clinical experience with MotionLoc® FCL screws for stabilization of distal femur fractures to assess their durability and potential complications.

Thirty-two consecutive patients with 33 distal femur fractures (AO/OTA types 33-A and 33-C) were prospectively enrolled at three trauma centers. Fractures were stabilized by plate osteosynthesis with MotionLoc® FCL screws without supplemental bone graft or bone morphogenic proteins. Thirty patients with 31 fractures were available for follow-up until union or revision. Follow-up visits at 6, 12, and 24 weeks comprised functional and radiographic assessment of implant fixation and fracture healing, including computed tomography scans at week 12. The primary endpoint was fracture healing in absence of complications and revision.

There was no incidence of implant breakage or diaphyseal fixation failure. Thirty of 31 fractures healed within 15.6 ± 6.2 weeks, as evident by bridging callus and pain-free load bearing. There were two revisions, one at 5 days post surgery to correct a mal-rotation, and one at 6 months post surgery to revise a non-union. Periosteal callus distribution at week 6 was symmetrical, with similar amounts of callus at the medial cortex (35%) anterior cortex (30%) and posterior cortex (35%). In 23 fractures (74%), callus formation extended to the lateral cortex under the plate.

Absence of hardware and fixation failure suggests that dynamic plating of distal femur fractures with FCL screws provides safe and effective fixation. Moreover, the amount and symmetric distribution of periosteal callus suggests that dynamic fixation with FCL screws may promote increased fracture healing over standard locked plating. However, this hypothesis on the stimulatory effect of dynamic fixation on fracture healing requires investigation in a future randomized control trial.


Recruitment information / eligibility

Status Completed
Enrollment 33
Est. completion date January 2013
Est. primary completion date May 2012
Accepts healthy volunteers No
Gender Both
Age group 17 Years and older
Eligibility Inclusion Criteria:

1. Patients with distal femur fracture (AO/OTA Type 33A and 33C)

2. Patients 17 years of age and over.

3. Patients able to be operated on by selected surgeons at the participating centers.

Exclusion Criteria:

1. Pregnancy

2. Patients who are enrolled in an investigational treatment trial.

3. Patients who are not expected to survive the follow-up period.

4. Considered an inappropriate participant by the study physician.

5. Revision surgery

6. Patients currently incarcerated or awaiting incarceration.

7. Severe spinal injury with neurological deficit resulting in paralysis.

8. Fracture fixed more then 28 days after injury.

9. Acute or chronic local or systemic infections

10. Periprosthetic fractures

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Locations

Country Name City State
United States Legacy Health System Portland Oregon

Sponsors (4)

Lead Sponsor Collaborator
Legacy Biomechanics Laboratory Slocum Center for Orthopaedics, Eugene, OR, University of Utah, Zimmer, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Fracture Healing Fracture healing is defined clinically by the ability of pain-free weight bearing, and radiographically by callus formation and bridging. 6, 12, and 24 weeks post surgery No
Secondary Periosteal Callus Size Periosteal callus size is assessed at the anterior, posterior, and medial aspects on radiographs using a validated computational algorithm. 6, 12, 24 weeks post surgery No
Secondary Bridging Callus from CT Cross-sectional image analysis, supported by 3-D rendering, to detect bony bridging at the anterior, posterior, and lateral aspects of the femur. 12 weeks post surgery No
Secondary Fixation Failure Assessed in terms of loss of alignment at 12 and 24 weeks post surgery 24 weeks post surgery No
Secondary Hardware failure Breakage of screw or plate 6, 12, 24 weeks post surgery No